Keke Palmer visited SiriusXM Studios today in New York to talk about her new film "One of Them Days," which is currently the No. 1 movie in the country. For her radio appearance, the "Nope" star ...

In the later months of 2024, high-end designer, Balenciaga, shared their latest range of footwear for fall 2025 — a shoe that ...

Below is Validea's guru fundamental report for TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR) (TEVA). Of the 22 guru strategies we follow, TEVA rates highest using our Twin Momentum Investor model based ...

Paul Mescal in "Gladiator II." Gladiator II— the sequel to 2000’s Gladiator starring Paul Mescal, Denzel Washington and Pedro Pascal, is coming soon to streaming on Paramount+. Rated R ...

Discover the Roman history and strategy games that will make you yell 'yield'! Dive into the world of Yield! Fall of Rome and ...

now's your chance to flex, pout, preen and show the world how powerful you are! If you are aged between 5-15 years old, grab a grown up and send us a short video of your best Gladiator moves!

“Gladiator II,” one of the year’s biggest action films and the sequel to Ridley Scott‘s Oscar-winning historical epic, will soon be streaming on Paramount+ on Jan. 21. “After his home is ...

Jan. 17 (UPI) --Gladiator II is coming to Paramount+. The film, which starts streaming Tuesday, stars Paul Mescal as Lucius, the son of Connie Nielsen's Lucilla. The movie is a sequel to the 2000 ...

Meara covers streaming service news for CNET. She graduated from the University of Texas at Austin with a degree in journalism. When she's not writing, she likes to dote over her cat, sip black ...

Gladiator II, Ridley Scott’s critically acclaimed follow-up to his Best Picture Oscar-winning Gladiator, is bound for streaming, set to premiere on Paramount+ in the U.S. and Canada on January 21.

Gladiator II will be available on Paramount+ on Tuesday, January 21st. One of the biggest action films of 2024, and director Ridley Scott’s sequel to his Oscar-winning epic from over two ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...